Analystreport

Sarepta Therapeutics (NASDAQ: SRPT) was downgraded by analysts at UBS from an "outperform" rating to a "market perform" rating.

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report